Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.
about
Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modificationsProtein lipoxidation: Detection strategies and challengesMeasurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.Catabolism of (2E)-4-hydroxy-2-nonenal via ω- and ω-1-oxidation stimulated by ketogenic diet.Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J miceCardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 ActivityAldehyde Dehydrogenase 2 Has Cardioprotective Effects on Myocardial Ischaemia/Reperfusion Injury via Suppressing Mitophagy.Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured Cardiomyocytes.Increased 4-hydroxy-2-nonenal-induced proteasome dysfunction is correlated with cardiac damage in streptozotocin-injected rats with isoproterenol infusion.Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble?Alternatives to the Streptozotocin-Diabetic Rodent.4-Hydroxy-2-nonenal: a critical target in oxidative stress?Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling.Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed ratsMelatonin Efficacy in Obese Leptin-Deficient Mice Heart.Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.Determination of peripheral neuropathy in high fat fed low dose streptozotocin treated female C57Bl/6J mice and Sprague-Dawley rats.Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
P2860
Q26824709-BF2D7723-0DE4-4951-8407-82A2B2C0CE08Q26824737-524514AF-0399-4F35-8FC9-7F11804255FBQ30248995-717BE6EE-38FD-4A3E-9061-ED041A78F8DBQ34509886-7051C460-B501-48A3-AD79-D437D11808D9Q35752230-5099AB38-72DD-49D5-9315-D3D7DC7E2D36Q36162437-731C4CF0-52D5-466D-AB11-7DFA94FA456AQ36818757-492C5D8F-904D-415E-B2EB-CA053ACB1DD3Q37718230-2ADC70C2-E833-419C-A44D-3847E7103B47Q38729174-C0A240A2-7D5E-4DC2-BED9-99F0FB1A7CE2Q38765976-352BBD80-677B-4018-B9E4-55C58C77334FQ38788160-E37C0D96-DE9E-4CCA-B5C9-3F92A729FE44Q38822212-56462C3B-781C-4E44-B366-9CAE8684B364Q38888477-3F577703-88BE-4168-9594-1F018964A1F9Q41520454-BC61A337-EF23-4B88-8210-C6218FAD0918Q41600084-E5C4FC26-FE8A-459E-B0A6-328453752CE5Q47163241-68C13092-7C42-41B1-A5BB-860747ED660FQ47845721-B6E1B2A5-EDF6-4B9C-A77E-07EFBE9FEDC4Q50141677-72CC861C-EA04-4783-818D-FD1DB119E32EQ55014723-55F8833E-01E9-4A8A-9C9F-ECAC0802C887
P2860
Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@ast
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@en
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@nl
type
label
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@ast
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@en
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@nl
prefLabel
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@ast
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@en
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@nl
P2093
P2860
P356
P1476
Impairment of aldehyde dehydro ...... with low-dose streptozotocin.
@en
P2093
Jieli Chen
Ruizhuo Ning
Suresh S Palaniyandi
Vishal R Mali
Xiao-Ping Yang
P2860
P304
P356
10.1177/1535370213520109
P577
2014-03-20T00:00:00Z